Matches in SemOpenAlex for { <https://semopenalex.org/work/W2802368997> ?p ?o ?g. }
- W2802368997 endingPage "1029" @default.
- W2802368997 startingPage "1023" @default.
- W2802368997 abstract "The relationship between obstructive sleep apnea (OSA) and platelet reactivity in patients undergoing percutaneous coronary intervention (PCI) has not been defined. The present prospective, single-center study explored the relationship between platelet reactivity and OSA in patients with PCI.A total of 242 patients were finally included in the study. OSA was screened overnight by polysomnography. Platelet reactivity was assessed with a sequential platelet counting method, and the platelet maximum aggregation ratio (MAR) and average aggregation ratio were calculated. All patients were assigned per apnea-hypopnea index (AHI) to non-OSA (n = 128) and OSA (n = 114) groups. The receiver operating characteristic curve analysis was used to evaluate the accuracy of AHI for high platelet reactivity (HPR) on aspirin and clopidogrel, and multivariable logistic regression was used to determine the independent predictors of HPR on aspirin and clopidogrel.Median AHI was significantly higher in the OSA group than in the non-OSA group (34.5 events/h vs. 8.1 events/h, Z = -13.422, P < 0.001). Likewise, median arachidonic acid- and adenosine diphosphate-induced maximum aggregation rate (MAR) in the OSA group was significantly higher than those in the non-OSA group (21.1% vs. 17.7%, Z = -3.525, P < 0.001 and 45.8% vs. 32.2%, Z = -5.708, P < 0.001, respectively). Multivariable logistic regression showed that OSA was the only independent predictor for HPR on aspirin (odds ratio [OR]: 1.055, 95% confidence interval [CI]: 1.033-1.077, P < 0.001) and clopidogrel (OR: 1.036, 95% CI: 1.017-1.056, P < 0.001). The cutoff value of AHI for HPR on aspirin was 45.2 events/h (sensitivity 47.1% and specificity 91.3%), whereas cutoff value of AHI for HPR on clopidogrel was 21.3 events/h (sensitivity 68.3% and specificity 67.7%).Platelet reactivity appeared to be higher in OSA patients with PCI despite having received a loading dose of aspirin and clopidogrel, and OSA might be an independent predictor of HPR on aspirin and clopidogrel.阻塞性睡眠呼吸暂停对经皮冠脉支架介入治疗患者血小板活性的影响摘要背景:目前阻塞性睡眠呼吸暂停与经皮冠脉支架介入治疗(PCI)患者血小板活性之间的关系尚未明确报道。本前瞻性单中心研究主要探究这两者之间的潜在联系。 方法:本研究最终纳入242名患者。利用多导睡眠监测仪检测睡眠呼吸暂停现象,并使用连续血小板检测的方法评估血小板功能,计算最大血小板聚集率(MAR)和平均血小板聚集率(AAR)。按照呼吸暂停低通气指数(AHI)将患者分为睡眠呼吸暂停(OSA)组(n=114)和非睡眠呼吸暂停(non-OSA)组(n=128)。使用ROC曲线评估AHI对阿司匹林和氯吡格雷高血小板反应性的诊断准确度,运用多元回归分析来确定阿司匹林和氯吡格雷高血小板反应性的独立预测因子。 结果:在OSA组中,AHI的中位数显著高于non-OSA组(34.5 events/h vs. 8.1 events/h, Z=-13.422, P<0.001)。而且,OSA组的AA和ADP诱导的最大血小板聚集率同样显著高于non-OSA组(分别为21.1% vs. 17.7%, Z=-3.525, P<0.001; 以及45.8% vs. 32.2%, Z=-5.708, P<0.001)。多元logistic回归分析显示OSA为阿司匹林和氯吡格雷高血小板反应性的独立预测因子(OR: 1.055, 95% CI: 1.033-1.077, P<0.001;以及OR: 1.036, 95% CI: 1.017-1.056, P<0.001)。预测阿司匹林高血小板反应性的AHI截断值为45.2 events/h (敏感性 47.1%, 特异性 91.3%),而预测氯吡格雷高血小板反应性的AHI截断值为21.3 events/h (敏感性 68.3%, 特异性 67.7%)。 结论:PCI患者虽然在术前接受了负荷剂量的阿司匹林和氯吡格雷,但OSA患者的血小板活性仍处于较高水平。OSA可能是阿司匹林和氯吡格雷高血小板反应性的独立预测因子。." @default.
- W2802368997 created "2018-05-17" @default.
- W2802368997 creator A5005706055 @default.
- W2802368997 creator A5016722530 @default.
- W2802368997 creator A5021173503 @default.
- W2802368997 creator A5050060219 @default.
- W2802368997 creator A5057008099 @default.
- W2802368997 creator A5069618403 @default.
- W2802368997 creator A5078101173 @default.
- W2802368997 date "2018-05-05" @default.
- W2802368997 modified "2023-10-18" @default.
- W2802368997 title "Obstructive Sleep Apnea Affecting Platelet Reactivity in Patients Undergoing Percutaneous Coronary Intervention" @default.
- W2802368997 cites W1582334813 @default.
- W2802368997 cites W2021366895 @default.
- W2802368997 cites W2047168605 @default.
- W2802368997 cites W2060092169 @default.
- W2802368997 cites W2063814790 @default.
- W2802368997 cites W2071912153 @default.
- W2802368997 cites W2076602637 @default.
- W2802368997 cites W2098933452 @default.
- W2802368997 cites W2117834225 @default.
- W2802368997 cites W2120482643 @default.
- W2802368997 cites W2130972341 @default.
- W2802368997 cites W2161785946 @default.
- W2802368997 cites W2374755824 @default.
- W2802368997 cites W2399320986 @default.
- W2802368997 cites W57582191 @default.
- W2802368997 cites W67896653 @default.
- W2802368997 doi "https://doi.org/10.4103/0366-6999.230732" @default.
- W2802368997 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5937308" @default.
- W2802368997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29692371" @default.
- W2802368997 hasPublicationYear "2018" @default.
- W2802368997 type Work @default.
- W2802368997 sameAs 2802368997 @default.
- W2802368997 citedByCount "7" @default.
- W2802368997 countsByYear W28023689972018 @default.
- W2802368997 countsByYear W28023689972020 @default.
- W2802368997 countsByYear W28023689972021 @default.
- W2802368997 countsByYear W28023689972022 @default.
- W2802368997 crossrefType "journal-article" @default.
- W2802368997 hasAuthorship W2802368997A5005706055 @default.
- W2802368997 hasAuthorship W2802368997A5016722530 @default.
- W2802368997 hasAuthorship W2802368997A5021173503 @default.
- W2802368997 hasAuthorship W2802368997A5050060219 @default.
- W2802368997 hasAuthorship W2802368997A5057008099 @default.
- W2802368997 hasAuthorship W2802368997A5069618403 @default.
- W2802368997 hasAuthorship W2802368997A5078101173 @default.
- W2802368997 hasBestOaLocation W28023689971 @default.
- W2802368997 hasConcept C126322002 @default.
- W2802368997 hasConcept C151956035 @default.
- W2802368997 hasConcept C156957248 @default.
- W2802368997 hasConcept C164705383 @default.
- W2802368997 hasConcept C2776006263 @default.
- W2802368997 hasConcept C2777628954 @default.
- W2802368997 hasConcept C2777849778 @default.
- W2802368997 hasConcept C2778205975 @default.
- W2802368997 hasConcept C2780400711 @default.
- W2802368997 hasConcept C2781326671 @default.
- W2802368997 hasConcept C42219234 @default.
- W2802368997 hasConcept C44249647 @default.
- W2802368997 hasConcept C45393284 @default.
- W2802368997 hasConcept C500558357 @default.
- W2802368997 hasConcept C71924100 @default.
- W2802368997 hasConcept C90924648 @default.
- W2802368997 hasConceptScore W2802368997C126322002 @default.
- W2802368997 hasConceptScore W2802368997C151956035 @default.
- W2802368997 hasConceptScore W2802368997C156957248 @default.
- W2802368997 hasConceptScore W2802368997C164705383 @default.
- W2802368997 hasConceptScore W2802368997C2776006263 @default.
- W2802368997 hasConceptScore W2802368997C2777628954 @default.
- W2802368997 hasConceptScore W2802368997C2777849778 @default.
- W2802368997 hasConceptScore W2802368997C2778205975 @default.
- W2802368997 hasConceptScore W2802368997C2780400711 @default.
- W2802368997 hasConceptScore W2802368997C2781326671 @default.
- W2802368997 hasConceptScore W2802368997C42219234 @default.
- W2802368997 hasConceptScore W2802368997C44249647 @default.
- W2802368997 hasConceptScore W2802368997C45393284 @default.
- W2802368997 hasConceptScore W2802368997C500558357 @default.
- W2802368997 hasConceptScore W2802368997C71924100 @default.
- W2802368997 hasConceptScore W2802368997C90924648 @default.
- W2802368997 hasIssue "9" @default.
- W2802368997 hasLocation W28023689971 @default.
- W2802368997 hasLocation W28023689972 @default.
- W2802368997 hasLocation W28023689973 @default.
- W2802368997 hasLocation W28023689974 @default.
- W2802368997 hasLocation W28023689975 @default.
- W2802368997 hasOpenAccess W2802368997 @default.
- W2802368997 hasPrimaryLocation W28023689971 @default.
- W2802368997 hasRelatedWork W2084673482 @default.
- W2802368997 hasRelatedWork W2170949977 @default.
- W2802368997 hasRelatedWork W2358185051 @default.
- W2802368997 hasRelatedWork W2363315954 @default.
- W2802368997 hasRelatedWork W2377201884 @default.
- W2802368997 hasRelatedWork W4376848313 @default.
- W2802368997 hasRelatedWork W45326695 @default.
- W2802368997 hasRelatedWork W979863887 @default.
- W2802368997 hasRelatedWork W2162886638 @default.
- W2802368997 hasRelatedWork W2527719101 @default.